Churcher, Ian
Janus Drug Discovery Consulting Ltd,
United Kingdom
2025 Rank: 188713
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Chemistry
SubField 1:
Medicinal & Biomolecular Chemistry
SubField 2:
Organic Chemistry
Rank in SubField 1: 814 out of 112089 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 188713 | 218560 |
| Total Cites | 504 | 513 |
| H-index | 9 | 9 |
| Hm-index | 2 | 2 |
| Number of Single Authored Papers | 3 | 3 |
| Total Cites to Single Authored Papers | 37 | 37 |
| Number of Single+First Authored Papers | 7 | 7 |
| Total Cites to Single+First Authored Papers | 42 | 42 |
| Number of Single+First+Last Authored Papers | 11 | 11 |
| Total Cites to Single+First+Last Authored Papers | 69 | 69 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 439 | 445 |
| Ratio of Total Citations to Distinct Citing Papers | 1.15 | 1.15 |
| Self-Citation Percentage |
1.75%
|
|
Churcher, Ian
Amphista Therapeutics Ltd,
United Kingdom
2024 Rank: 115148
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Chemistry
SubField 1:
Medicinal & Biomolecular Chemistry
SubField 2:
Organic Chemistry
Rank in SubField 1: 416 out of 105998 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 115148 | 131168 |
| Total Cites | 528 | 532 |
| H-index | 9 | 9 |
| Hm-index | 2 | 2 |
| Number of Single Authored Papers | 3 | 3 |
| Total Cites to Single Authored Papers | 62 | 62 |
| Number of Single+First Authored Papers | 7 | 7 |
| Total Cites to Single+First Authored Papers | 67 | 67 |
| Number of Single+First+Last Authored Papers | 11 | 11 |
| Total Cites to Single+First+Last Authored Papers | 110 | 110 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 444 | 445 |
| Ratio of Total Citations to Distinct Citing Papers | 1.19 | 1.20 |
| Self-Citation Percentage |
0.75%
|
|
Churcher, Ian
Amphista Therapeutics Ltd,
United Kingdom
2023 Rank: 127672
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Chemistry
SubField 1:
Medicinal & Biomolecular Chemistry
SubField 2:
Organic Chemistry
Rank in SubField 1: 497 out of 99369 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 127672 | 139447 |
| Total Cites | 461 | 473 |
| H-index | 8 | 9 |
| Hm-index | 3 | 3 |
| Number of Single Authored Papers | 3 | 3 |
| Total Cites to Single Authored Papers | 51 | 51 |
| Number of Single+First Authored Papers | 7 | 7 |
| Total Cites to Single+First Authored Papers | 59 | 59 |
| Number of Single+First+Last Authored Papers | 11 | 11 |
| Total Cites to Single+First+Last Authored Papers | 95 | 95 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 388 | 395 |
| Ratio of Total Citations to Distinct Citing Papers | 1.19 | 1.20 |
| Self-Citation Percentage |
2.54%
|
|
Churcher, Ian
Amphista Therapeutics Ltd,
United Kingdom
2022 Rank: 109170
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Chemistry
SubField 1:
Medicinal & Biomolecular Chemistry
SubField 2:
Organic Chemistry
Rank in SubField 1: 377 out of 94672 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 109170 | 112390 |
| Total Cites | 517 | 547 |
| H-index | 7 | 8 |
| Hm-index | 3 | 3 |
| Number of Single Authored Papers | 3 | 3 |
| Total Cites to Single Authored Papers | 60 | 62 |
| Number of Single+First Authored Papers | 7 | 7 |
| Total Cites to Single+First Authored Papers | 67 | 69 |
| Number of Single+First+Last Authored Papers | 11 | 11 |
| Total Cites to Single+First+Last Authored Papers | 96 | 98 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 430 | 441 |
| Ratio of Total Citations to Distinct Citing Papers | 1.20 | 1.24 |
| Self-Citation Percentage |
5.48%
|
|
Churcher, Ian
GlaxoSmithKline plc.,
United Kingdom
2021 Rank: 88401
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Chemistry
SubField 1:
Organic Chemistry
SubField 2:
Medicinal & Biomolecular Chemistry
Rank in SubField 1: 1259 out of 144918 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 88401 | 96983 |
| Total Cites | 763 | 802 |
| H-index | 9 | 10 |
| Hm-index | 3 | 3 |
| Number of Single Authored Papers | 3 | 3 |
| Total Cites to Single Authored Papers | 119 | 120 |
| Number of Single+First Authored Papers | 7 | 7 |
| Total Cites to Single+First Authored Papers | 132 | 133 |
| Number of Single+First+Last Authored Papers | 10 | 10 |
| Total Cites to Single+First+Last Authored Papers | 175 | 176 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 626 | 641 |
| Ratio of Total Citations to Distinct Citing Papers | 1.22 | 1.25 |
| Self-Citation Percentage |
4.86%
|
|
Churcher, Ian
GlaxoSmithKline plc.,
United Kingdom
2020 Rank: 86902
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Chemistry
SubField 1:
Organic Chemistry
SubField 2:
Medicinal & Biomolecular Chemistry
Rank in SubField 1: 1377 out of 111388 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 86902 | 94036 |
| Total Cites | 558 | 592 |
| H-index | 7 | 8 |
| Hm-index | 3 | 3 |
| Number of Single Authored Papers | 3 | 3 |
| Total Cites to Single Authored Papers | 87 | 88 |
| Number of Single+First Authored Papers | 9 | 9 |
| Total Cites to Single+First Authored Papers | 98 | 99 |
| Number of Single+First+Last Authored Papers | 12 | 12 |
| Total Cites to Single+First+Last Authored Papers | 157 | 159 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 483 | 495 |
| Ratio of Total Citations to Distinct Citing Papers | 1.16 | 1.20 |
| Self-Citation Percentage |
5.74%
|
|
Related Profiles
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.